Skip to content
AnalystLens

EMERSON ELECTRIC CO 8-K Report, Financial Results (Aug 4, 2026)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed August 4, 2026
Period End
August 4, 2026
Security
EMR
In the record · 2016–202610-K1010-Q338-K163

EMR filed 10 annual reports (10-K), 33 quarterly reports (10-Q) and 163 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’18May ’18
  2. Leadership change8-K · Mar ’21Mar ’21
  3. Deal closed8-K · Jun ’23Jun ’23
  4. Leadership change8-K · Mar ’25Mar ’25

Summary

Summary of the 8-K filed August 4, 2026. Cited figures are marked; the original filing is the authoritative source.

Emerson Electric (NYSE: EMR) reported fiscal third-quarter 2026 results for the quarter ended June 30, 2026, delivering strong top- and bottom-line growth and raising its full-year 2026 outlook.

Net sales rose 7% to $4,873 milliona (6% underlying), underlying orders grew 7% led by Software & Systems, and GAAP EPS increased 24% to $1.28. Adjusted EPS rose 13% to $1.71, and adjusted segment EBITA margin expanded 140 bps to 28.5%. Operating cash flow of $1,425 million (up 34%) and free cash flow of $1,323 million (up 36%) were also well ahead of the prior year.

Management raised its 2026 outlook, now guiding to adjusted EPS of roughly $6.55b, operating cash flow of about $4.1 billion, and free cash flow of about $3.6 billion, with full-year underlying sales growth of approximate 3.5%. The quarter's GAAP results were helped by a one-time $82 million pretax benefit from IEEPA tariff refunds, which management excluded from adjusted EPS. Balance sheet activity was significant: cash rose to $2.18 billion, while short-term borrowings increased to $5.59 billion and long-term debt declined to $7.53 billion.

Management is pivoting capital allocation toward shareholder returns, with the 2026 plan assuming roughly $2.2 billionc returned via about $1 billion of buybacks and about $1.2 billion of dividends. The company also declared a quarterly dividend of $0.555 per share, payable September 10, 2026. Investors should note several cautionary items.

Intangibles amortization and restructuring costs remain elevated, with Q3 restructuring of $99 milliond up from $41 million a year earlier, and Final Control restructuring rising sharply. Management also flagged an ongoing Middle East conflict as fluid, and the company continues to face currency and tariff exposure. Full-year underlying sales growth of ~3.5% is noticeably below the ~6% achieved in Q3, implying a slower Q4 at ~5% underlying, which investors should weigh against the strong quarter.

Key Highlights

  1. Net sales grew 7% to $4,873M (6% underlying); underlying orders rose 7%, led by Software & Systems (Test & Measurement +23% reported sales growth).
  2. Adjusted EPS rose 13% to $1.71 and GAAP EPS rose 24% to $1.28; the quarter included an $82M pretax IEEPA tariff refund benefit excluded from adjusted results.
  3. Adjusted segment EBITA margin expanded 140 bps to 28.5% ($1,387M), with Intelligent Devices margin up to 27.9% and Software & Systems to 31.8%.
  4. Operating cash flow rose 34% to $1,425M and free cash flow rose 36% to $1,323M in Q3.
  5. 2026 outlook raised: adjusted EPS ~$6.55, operating cash flow ~$4.1B, free cash flow ~$3.6B; net sales growth ~5% and underlying sales growth ~3.5% for the year.
  6. Capital allocation pivot to shareholder returns: ~$2.2B planned in 2026 (~$1B buybacks, ~$1.2B dividends); quarterly dividend declared at $0.555 per share.
  7. Restructuring costs rose to $99M in Q3 from $41M, and short-term borrowings increased to $5.59B, warranting monitoring of cost and leverage trends.

Frequently Asked Questions

  1. Did Emerson's third-quarter performance beat expectations and drive the guidance raise?

    Management said sales, margin expansion, earnings and cash flow all exceeded expectations, and it raised full-year guidance on the strong quarter and healthy demand. Adjusted EPS of $1.71 grew 13% year over year.

  2. How much of the quarter's earnings came from one-time items?

    The quarter included an $82M pretax benefit from IEEPA tariff refunds (about $0.11 per share), which GAAP results include but adjusted EPS excludes. Restructuring costs of $99M and intangibles amortization of $253M were also excluded from adjusted figures.

  3. What does the 2026 guidance imply for the fourth quarter?

    Full-year adjusted EPS of ~$6.55 less the nine-month results implies a Q4 adjusted EPS of ~$1.85, and Q4 underlying sales growth is guided to ~5%, versus ~3.5% for the full year. Q4 GAAP EPS is guided at ~$1.45.

  4. How is Emerson returning cash to shareholders and is it funded from operations?

    The 2026 outlook assumes about $2.2B returned to shareholders, comprising about $1B in buybacks and about $1.2B in dividends. Guided 2026 free cash flow of ~$3.6B covers that plan, though the company's short-term borrowings rose to $5.59B at June 30, 2026.

  5. What are the main risks flagged in the filing?

    The filing cites the scope and impact of the Russia-Ukraine and Middle East conflicts, currency and economic conditions, tariffs, and inflation. Management specifically called the Middle East conflict fluid, and tariff and currency swings continue to affect results.